Times Square Capital Management, LLC Insmed Inc Transaction History
Times Square Capital Management, LLC
- $6.24 Billion
- Q3 2025
A detailed history of Times Square Capital Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Times Square Capital Management, LLC holds 425,085 shares of INSM stock, worth $82.1 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
425,085
Previous 873,491
51.33%
Holding current value
$82.1 Million
Previous $87.9 Million
30.36%
% of portfolio
0.98%
Previous 1.36%
Shares
5 transactions
Others Institutions Holding INSM
# of Institutions
644Shares Held
208MCall Options Held
3.83MPut Options Held
4.26M-
Jpmorgan Chase & CO New York, NY23MShares$4.45 Billion0.22% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y920.5MShares$3.95 Billion89.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.9MShares$3.85 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.76 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA7.55MShares$1.46 Billion0.18% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $26.2B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...